| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.71▼ | 10.71▼ | 10.71▲ | 10.15▲ | 10.28▲ |
| MA10 | 10.72▼ | 10.68▲ | 10.59▲ | 9.85▲ | 9.76▲ |
| MA20 | 10.69▲ | 10.52▲ | 10.40▲ | 10.12▲ | 9.10▲ |
| MA50 | 10.60▲ | 10.14▲ | 9.89▲ | 9.53▲ | 7.80▲ |
| MA100 | 10.43▲ | 9.82▲ | 9.92▲ | 9.05▲ | 7.55▲ |
| MA200 | 10.02▲ | 10.04▲ | 10.32▲ | 7.87▲ | 8.82▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | 0.000▼ | 0.020▲ | 0.020▲ | 0.116▲ |
| RSI | 53.982▲ | 62.010▲ | 70.330▲ | 59.147▲ | 61.532▲ |
| STOCH | 42.222 | 87.478▲ | 91.962▲ | 61.244 | 56.331 |
| WILL %R | -50.000 | -9.677▲ | -7.500▲ | -5.397▲ | -42.626 |
| CCI | -29.355 | 61.470 | 94.977 | 131.531▲ | 66.079 |
|
Thursday, May 14, 2026 12:30 AM
Fort Lee, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative ...
|
|
Wednesday, December 17, 2025 07:06 AM
Resistance remains one of the biggest unsolved problems in modern cancer treatment, and nowhere is that more evident than in lung cancer. AstraZeneca’s Tagrisso has become the gold standard for ...
|
|
Tuesday, November 25, 2025 05:00 AM
Fort Lee, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NVCT) (NASDAQ: NVCT, the “Company”), a clinical stage biopharmaceutical company focused on the development of innovative ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/06/26 | 10.36 | 10.795 | 10.1144 | 10.71 | 69,095 |
| 11/06/26 | 10.41 | 10.55 | 9.94 | 10.51 | 62,112 |
| 10/06/26 | 9.67 | 10.45 | 9.67 | 10.31 | 99,919 |
| 09/06/26 | 9.52 | 9.86 | 9.3501 | 9.80 | 63,696 |
| 08/06/26 | 9.75 | 9.95 | 9.39 | 9.42 | 41,436 |
| 05/06/26 | 9.44 | 9.775 | 9.3301 | 9.54 | 73,954 |
| 04/06/26 | 9.33 | 9.69 | 9.31 | 9.67 | 34,938 |
| 03/06/26 | 9.50 | 9.675 | 9.22 | 9.31 | 68,229 |
| 02/06/26 | 9.61 | 9.7199 | 9.47 | 9.51 | 69,396 |
| 01/06/26 | 9.62 | 9.995 | 9.51 | 9.75 | 98,116 |
|
|
||||
|
|
||||
|
|